Critical Diagnostics Showcases Cardiac Biomarker At Heart Failure Nurses …MarketWatch (press release)SAN DIEGO, Jul 02, 2012 (BUSINESS WIRE) — Critical Diagnostics, makers of the Presage(R) ST2 Assay, participated in the annual meeting for the Ameri…
Prochymal Significantly Reduces Hypertrophy, Arrhythmia and Progression to …MarketWatch (press release)The mechanistic data is complemented by clinical data showing treatment with Prochymal resulted in a statistically significant reduction in heart f…
Antares Pharma, Inc. today announced the appointment of Jonathan S. Jaffe MD to the position of Vice President of Clinical Development. Jonathan’s background include
Daily News & AnalysisWestern silhouettes with an Indian heartDaily News & AnalysisNandita Mahtani's presents her Summer-Monsoon collection with the Blenders Pride Magical Nights across six cities in India; DNA catches up with her for a quick tête-…
Stem cells may cure liver failureKorea TimesPharmicell, a Korean pharmaceutical company developing stem cell therapeutics, said Monday that it has submitted a plan for the commercialization of “Livercellgram,” a stem cell therapy for liver failure,…
Kuala Lumpur: The unreasonable requirements imposed on St John Ambulance Malaysia (SJAM) in operating dialysis centres is "criminal", says J
8-year-old from Mauritius gets liver donation from his motherTimes of India8-year-old Jean Marie was suffering from Budd Chairi syndrome, a decomposed state of liver.
NewsPoint AfricaReplacement liver soon to be a realityTimes of IndiaAn Indian origin scientist and her team are hopeful that new advances in tissue engineering and regenerative medicine could one day make a replacement liver from a patient's own ce…
Zee NewsReplacement liver from patient`s own cells coming soonZee NewsA replacement liver from a patient`s own cells, or animal muscle tissue that could be cut into steaks without ever being inside a cow.
Despite likely new MS drugs, US neurologists continue to see significant near …The Pharma LetterIn fact, interest in BG-12, along with Biogen Idec's PEG-Avonex, Abbott/Biogen Idec's daclizumab and Roche/Genentech's ocrelizumab, has increa…